Given that membrane-anchored sNKG2DLs have opposing effects on NKG2D activation and that ULBP6 exists in both forms in patients with cancer, we sought to understand the net effect of membrane and sULBP6 on the tumor microenvironment in vivo. Here, KLRK1 is linked to cancer.